1-5 of 5
Anne Armstrong
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Paclitaxel plus Eftilagimod Alpha, a Soluble LAG-3 Protein, in Metastatic, HR+ Breast Cancer: Results from AIPAC, a Randomized, Placebo Controlled Phase IIb Trial

Hans Wildiers, Anne Armstrong, Eveline Cuypere, Florence Dalenc, Luc Dirix, Steve Chan, Frederik Marme, Carolina P. Schröder, Jens Huober, Francois P. Duhoux, Peter Vuylsteke, Agnes Jager, Etienne Brain, Sherko Kuemmel, Zsuzsanna Pápai, Catharina Willemien Menke-van der Houven van Oordt, Luca Perjesi, Christian Mueller, Chrystelle Brignone, Frederic Triebel
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (3): 532–541.
https://doi.org/10.1158/1078-0432.CCR-23-1173
Published: 01 February 2024
View article titled, Paclitaxel plus Eftilagimod Alpha, a Soluble LAG-3 Protein, in Metastatic, HR<sup>+</sup> Breast Cancer: Results from AIPAC, a Randomized, Placebo Controlled Phase IIb Trial
Open the PDF for Paclitaxel plus Eftilagimod Alpha, a Soluble LAG-3 Protein, in Metastatic, HR<sup>+</sup> Breast Cancer: Results from AIPAC, a Randomized, Placebo Controlled Phase IIb Trial in another window
Includes: Supplementary data
Journal Articles

VERONICA: Randomized Phase II Study of Fulvestrant and Venetoclax in ER-Positive Metastatic Breast Cancer Post-CDK4/6 Inhibitors – Efficacy, Safety, and Biomarker Results

Geoffrey J. Lindeman, Tharu M. Fernando, Rebecca Bowen, Katarzyna J. Jerzak, Xinni Song, Thomas Decker, Frances Boyle, Steve McCune, Anne Armstrong, Catherine Shannon, Gianfilippo Bertelli, Ching-Wei Chang, Rupal Desai, Kushagra Gupta, Timothy R. Wilson, Aulde Flechais, Aditya Bardia
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (15): 3256–3267.
https://doi.org/10.1158/1078-0432.CCR-21-3811
Published: 02 August 2022
View article titled, VERONICA: Randomized Phase II Study of Fulvestrant and Venetoclax in ER-Positive Metastatic Breast Cancer Post-CDK4/6 Inhibitors – Efficacy, Safety, and Biomarker Results
Open the PDF for VERONICA: Randomized Phase II Study of Fulvestrant and Venetoclax in ER-Positive Metastatic Breast Cancer Post-CDK4/6 Inhibitors – Efficacy, Safety, and Biomarker Results in another window
Includes: Supplementary data
Journal Articles

Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results

Nigel Bundred, Nuria Porta, Adrian Murray Brunt, Angela Cramer, Andrew Hanby, Abeer M. Shaaban, Emad A. Rakha, Anne Armstrong, Ramsey I. Cutress, David Dodwell, Marie A. Emson, Abigail Evans, Sue M. Hartup, Kieran Horgan, Sarah E. Miller, Stuart A. McIntosh, James P. Morden, Jay Naik, Sankaran Narayanan, Jane Ooi, Anthony I. Skene, David A. Cameron, Judith M. Bliss
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (7): 1323–1334.
https://doi.org/10.1158/1078-0432.CCR-21-3177
Published: 01 April 2022
View article titled, Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results
Open the PDF for Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results in another window
Includes: Supplementary data
Journal Articles

Personalized Detection of Circulating Tumor DNA Antedates Breast Cancer Metastatic Recurrence

Raoul Charles Coombes, Karen Page, Raheleh Salari, Robert K. Hastings, Anne Armstrong, Samreen Ahmed, Simak Ali, Susan Cleator, Laura Kenny, Justin Stebbing, Mark Rutherford, Himanshu Sethi, Anna Boydell, Ryan Swenerton, Daniel Fernandez-Garcia, Kelly L.T. Gleason, Katie Goddard, David S. Guttery, Zoe J. Assaf, Hsin-Ta Wu, Prashanthi Natarajan, David A. Moore, Lindsay Primrose, Scott Dashner, Antony S. Tin, Mustafa Balcioglu, Ramya Srinivasan, Svetlana V. Shchegrova, Alexander Olson, Dina Hafez, Paul Billings, Alexey Aleshin, Farah Rehman, Bradley J. Toghill, Allison Hills, Maggie C. Louie, Cheng-Ho Jimmy Lin, Bernhard G. Zimmermann, Jaqueline A. Shaw
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2019) 25 (14): 4255–4263.
https://doi.org/10.1158/1078-0432.CCR-18-3663
Published: 15 July 2019
View article titled, Personalized Detection of Circulating Tumor DNA Antedates Breast Cancer Metastatic Recurrence
Open the PDF for Personalized Detection of Circulating Tumor DNA Antedates Breast Cancer Metastatic Recurrence in another window
Includes: Supplementary data
Journal Articles

Circulating Biomarkers and Resistance to Endocrine Therapy in Metastatic Breast Cancers: Correlative Results from AZD9496 Oral SERD Phase I Trial

Costanza Paoletti, Gaia Schiavon, Emily M. Dolce, Elizabeth P. Darga, T. Hedley Carr, Joseph Geradts, Matthias Hoch, Teresa Klinowska, Justin Lindemann, Gayle Marshall, Shethah Morgan, Parul Patel, Vicky Rowlands, Nitharsan Sathiyayogan, Kimberly Aung, Erika Hamilton, Manish Patel, Anne Armstrong, Komal Jhaveri, Seock-Ah Im, Nadia Iqbal, Fouziah Butt, Caroline Dive, Elizabeth A. Harrington, J. Carl Barrett, Richard Baird, Daniel F. Hayes
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2018) 24 (23): 5860–5872.
https://doi.org/10.1158/1078-0432.CCR-18-1569
Published: 03 December 2018
View article titled, Circulating Biomarkers and Resistance to Endocrine Therapy in Metastatic Breast Cancers: Correlative Results from AZD9496 Oral SERD Phase I Trial
Open the PDF for Circulating Biomarkers and Resistance to Endocrine Therapy in Metastatic Breast Cancers: Correlative Results from AZD9496 Oral SERD Phase I Trial in another window
Includes: Supplementary data